Literature DB >> 22990018

Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.

Adam Cuker1, Phyllis A Gimotty, Mark A Crowther, Theodore E Warkentin.   

Abstract

The 4Ts is a pretest clinical scoring system for heparin-induced thrombocytopenia (HIT). Although widely used in clinical practice, its predictive value for HIT in diverse settings and patient populations is unknown. We performed a systematic review and meta-analysis to estimate the predictive value of the 4Ts in patients with suspected HIT. We searched PubMed, Cochrane Database, and ISI Web of Science for studies that included patients with suspected HIT, who were evaluated by both the 4Ts and a reference standard against which the 4Ts could be compared. Quality of eligible studies was assessed by QUADAS-2 criteria. Thirteen studies, collectively involving 3068 patients, fulfilled eligibility criteria. A total of 1712 (55.8%) patients were classified by 4Ts score as having a low probability of HIT. The negative predictive value of a low probability 4Ts score was 0.998 (95% CI, 0.970-1.000) and remained high irrespective of the party responsible for scoring, the prevalence of HIT, or the composition of the study population. The positive predictive value of an intermediate and high probability 4Ts score was 0.14 (0.09-0.22) and 0.64 (0.40-0.82), respectively. A low probability 4Ts score appears to be a robust means of excluding HIT. Patients with intermediate and high probability scores require further evaluation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990018      PMCID: PMC3501714          DOI: 10.1182/blood-2012-07-443051

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

Authors:  J Amiral; F Bridey; M Dreyfus; A M Vissoc; E Fressinaud; M Wolf; D Meyer
Journal:  Thromb Haemost       Date:  1992-07-06       Impact factor: 5.249

Review 2.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Meta-analysis of diagnostic accuracy studies accounting for disease prevalence: alternative parameterizations and model selection.

Authors:  Haitao Chu; Lei Nie; Stephen R Cole; Charles Poole
Journal:  Stat Med       Date:  2009-08-15       Impact factor: 2.373

4.  The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients.

Authors:  Mark Andrew Crowther; Deborah J Cook; Martin Albert; David Williamson; Maureen Meade; John Granton; Yoanna Skrobik; Stephan Langevin; Sangeeta Mehta; Paul Hebert; Gordon H Guyatt; William Geerts; Christian Rabbat; James Douketis; Nicole Zytaruk; Joanne Sheppard; Andreas Greinacher; Theodore E Warkentin
Journal:  J Crit Care       Date:  2010-02-10       Impact factor: 3.425

5.  Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome.

Authors:  Maureen A Smythe; Theodore E Warkentin; Amy L Woodhouse; Dana Zakalik
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

6.  A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.

Authors:  Linda J Demma; Anne M Winkler; Jerrold H Levy
Journal:  Anesth Analg       Date:  2011-07-25       Impact factor: 5.108

7.  A randomized trial of ways to describe test accuracy: the effect on physicians' post-test probability estimates.

Authors:  Milo A Puhan; Johann Steurer; Lucas M Bachmann; Gerben ter Riet
Journal:  Ann Intern Med       Date:  2005-08-02       Impact factor: 25.391

8.  A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia.

Authors:  Barbara Denys; Veronique Stove; Jan Philippé; Katrien Devreese
Journal:  Thromb Res       Date:  2008-06-26       Impact factor: 3.944

9.  Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American specialized coagulation laboratories.

Authors:  Elizabeth A Price; Catherine P M Hayward; Karen A Moffat; Jane C Moore; Theodore E Warkentin; James L Zehnder
Journal:  Thromb Haemost       Date:  2007-12       Impact factor: 5.249

10.  Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.

Authors:  C Pouplard; P Gueret; M Fouassier; C Ternisien; M Trossaert; S Régina; Y Gruel
Journal:  J Thromb Haemost       Date:  2007-03-14       Impact factor: 5.824

View more
  95 in total

1.  The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia.

Authors:  Gang Zheng; Michael B Streiff; Clifford M Takemoto; Jennifer Bynum; Elise Gelwan; Jayesh Jani; Danielle Judge; Thomas S Kickler
Journal:  Clin Appl Thromb Hemost       Date:  2017-08-04       Impact factor: 2.389

2.  Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know?

Authors:  Jason H Karnes
Journal:  Pharmacogenomics       Date:  2018-11-06       Impact factor: 2.533

Review 3.  Drug-associated thrombocytopenia.

Authors:  Tamam Bakchoul; Irene Marini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 4.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 5.  Heparin-induced thrombocytopenia.

Authors:  Grace M Lee; Gowthami M Arepally
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

6.  A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.

Authors:  Anand Padmanabhan; Curtis G Jones; Brian R Curtis; Daniel W Bougie; Mia J Sullivan; Namrata Peswani; Janice G McFarland; Daniel Eastwood; Demin Wang; Richard H Aster
Journal:  Chest       Date:  2016-02-19       Impact factor: 9.410

7.  STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass.

Authors:  Linda Shore-Lesserson; Robert A Baker; Victor Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John Hammon
Journal:  J Extra Corpor Technol       Date:  2018-03

8.  A case of heparin-induced thrombocytopenia with subacute stent thrombosis, multiple cerebral infarction, and acute limb ischemia.

Authors:  Hiroyuki Suzuki; Takashi Tsunematsu; Hironori Takahashi; Suguru Yasuda; Daiki Gyotoku; Keisuke Miyajima; Masao Takahashi; Satoshi Umemura; Kazuo Kimura
Journal:  J Cardiol Cases       Date:  2017-03-07

9.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Gowthami M Arepally; Beng H Chong; Douglas B Cines; Andreas Greinacher; Yves Gruel; Lori A Linkins; Stephen B Rodner; Sixten Selleng; Theodore E Warkentin; Ashleigh Wex; Reem A Mustafa; Rebecca L Morgan; Nancy Santesso
Journal:  Blood Adv       Date:  2018-11-27

10.  Heparin-induced thrombocytopenia: ELISA optical density value and 4T score in correlation with panel donor platelets activation in functional flow cytometric assay.

Authors:  Klara Železnik; Primož Rožman; Eva Kocjan; Elvira Maličev
Journal:  Blood Transfus       Date:  2020-10-09       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.